Phosphatidylinositol (3,5)-bisphosphate (PI3,5P2), a relatively unstudied signaling lipid, is required in all eukaryotes and cell-types tested. Defects in PI3,5P2 levels specifically lead to profound neurological defects. For example, a significant fraction of amylotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) patients have heterozygous mutations in Fig4, a protein that functions in the synthesis and turnover of PI3,5P2. Moreover, selected mutations in Fig4 lead to a form of Charcot-Marie Tooth syndrome that is early onset and causes paraplegia/quadriplegia. Consistent with these human diseases, we found that depletion of PI3,5P2 leads to neurological defects and embryonic lethality in mice. These studies and others predict that defects in PI3,5P2 metabolism underlie many neurodegenerative disorders. In order to identify and ultimately treat these diseases, we must first determine how the levels of this lipid are regulated, as well as determine the pathways that are regulated by PI3,5P2. While the long-term goal is to treat human disease, the yeast, Saccharomyces cerevisiase, provides unique advantages. Most of the machinery that regulates PI3,5P2 levels is conserved from yeast to humans. In addition, our newly identified candidate pathways directly upstream and downstream of PI3,5P2, are conserved as well. Thus, results from yeast studies will likely provide significant insights into PI3,5P2 function and regulation in humans. Importantly, the versatility of classical and global approaches to yeast genetics combined with the facility of performing microscopy and biochemistry on large numbers of cells, will enable us to rapidly identify and assign functions to proteins required for these pathways. Our goals are to: 1) Determine how the Vac14 complex functions in both the synthesis and turnover of PI3,5P2. 2) Determine how the cyclin, Pho80 and its kinase Pho85, act upstream of the Vac14 complex to regulate PI3,5P2 levels. 3) Complete a global screen designed to identify downstream molecular targets and pathways that are regulated by PI3,5P2, and then choose selected targets including the unexpected target, TORC1, to determine the how regulation by PI3,5P2 is achieved.

Public Health Relevance

Phosphatidylinositol (3,5)-bisphosphate (PI3,5P2), is required in all cell-types tested. However defects in PI3,5P2 levels most acutely affect neural cells, and low levels of PI3,5P2 lead to severe neurological disorders. The overall goals of this application are to 1) Determine the mechanisms the regulate PI3,5P2 levels, 2) Identify upstream pathways that signal the stimulus-induced acute changes in PI3,5P2, 3) Identify and characterize the downstream pathways that require PI3,5P2 for their function. Results of these studies should provide new insights into the roles and regulation of PI3,5P2 and will provide a basis for determining to roles of PI3,5P2 in the nervous system.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM050403-20
Application #
8424279
Study Section
Special Emphasis Panel (ZRG1-CB-N (02))
Program Officer
Chin, Jean
Project Start
1994-01-01
Project End
2015-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
20
Fiscal Year
2013
Total Cost
$412,658
Indirect Cost
$147,283
Name
University of Michigan Ann Arbor
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
McCartney, Amber J; Zhang, Yanling; Weisman, Lois S (2014) Phosphatidylinositol 3,5-bisphosphate: low abundance, high significance. Bioessays 36:52-64
Li, Sheena Claire; Diakov, Theodore T; Xu, Tao et al. (2014) The signaling lipid PI(3,5)P? stabilizes V?-V(o) sector interactions and activates the V-ATPase. Mol Biol Cell 25:1251-62
McCartney, Amber J; Zolov, Sergey N; Kauffman, Emily J et al. (2014) Activity-dependent PI(3,5)P2 synthesis controls AMPA receptor trafficking during synaptic depression. Proc Natl Acad Sci U S A 111:E4896-905
Jin, Natsuko; Mao, Kai; Jin, Yui et al. (2014) Roles for PI(3,5)P2 in nutrient sensing through TORC1. Mol Biol Cell 25:1171-85
Li, Xinran; Wang, Xiang; Zhang, Xiaoli et al. (2013) Genetically encoded fluorescent probe to visualize intracellular phosphatidylinositol 3,5-bisphosphate localization and dynamics. Proc Natl Acad Sci U S A 110:21165-70
Bridges, Dave; Fisher, Kaleigh; Zolov, Sergey N et al. (2012) Rab5 proteins regulate activation and localization of target of rapamycin complex 1. J Biol Chem 287:20913-21
Jin, Natsuko; Chow, Clement Y; Liu, Li et al. (2008) VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse. EMBO J 27:3221-34
Zhang, Yanling; Zolov, Sergey N; Chow, Clement Y et al. (2007) Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc Natl Acad Sci U S A 104:17518-23
Xing, Liyu; Remick, Daniel G (2007) Mechanisms of oxidant regulation of monocyte chemotactic protein 1 production in human whole blood and isolated mononuclear cells. Shock 28:178-85
Duex, Jason E; Nau, Johnathan J; Kauffman, Emily J et al. (2006) Phosphoinositide 5-phosphatase Fig 4p is required for both acute rise and subsequent fall in stress-induced phosphatidylinositol 3,5-bisphosphate levels. Eukaryot Cell 5:723-31

Showing the most recent 10 out of 25 publications